HIV and Hepatitis.com Articles on Tuberculosis

U.S. Public Health Service Tuberculosis Guidelines

What Is the Optimal TB Therapy Duration for Preventing Relapse in HIV Patients on HAART? - 2/24/06

Once Daily Regimen of Saquinavir, Ritonavir, Didanosine, and Lamivudine in HIV Patients on Standard Tuberculosis Therapy - 11/02/05

Bayer Offers Moxifloxacin, a Promising New Antibiotic in the Fight against TB and AIDS - 10/19/05

Appropriate Dose of Efavirenz Is Unclear for HIV Patients with Tuberculosis Receiving HAART and Rifampicin - 9/23/05

The Importance of Recent Infection with Mycobacterium Tuberculosis in an Area with High HIV Prevalence - 7/11/05

Outcome of Tuberculosis in HIV Positive Children - 7/06/05

Promising New Anti-tuberculosis Drug PA-824 Enters Clinical Trials - 6/15/05

Immune Reconstitution Disease Is Associated with Mycobacterial Infections in HIV Patients Receiving Antiretrovirals - 6/08/05

Tuberculosis: An Old Disease Needs New Cures - 3/28/05

Global Campaign Against Tuberculosis Makes Headway, but AIDS and Africa Have Big Problems - 3/25/05

Toward Defining the Incidence, Risk Factors and Long-term Outcome of a Unique, HAART-related Disease: Immune Reconstitution Inflammatory Syndrome (IRIS) - 3/11/05

Short-Course Therapy with Rifampin plus Isoniazid, Compared with Standard Therapy with Isoniazid, for Latent Tuberculosis Infection - 2/14/05

Incidence of Immune Reconstitution Syndrome in HIV-Tuberculosis Coinfected Patients in India - 2/11/05

Roche Issues Drug Interaction Warning on Hepatocellular Toxicity in Healthy Volunteers Receiving TB Drug Rifampin and Saquinavir/Ritonavir - 2/09/05

Cotrimoxazole Prophylaxis for TB Effectively Reduces Adult Death Rates in Rural South Africa - 2/09/05

Pharmacokinetic Study of Tenofovir Combined with Rifampin in Healthy Volunteers - 2/07/05

Effectiveness of Generic Fixed-Dose Combinations of HAART in India - 2/07/05

The Risk of Acquiring Tuberculosis (TB) Increases Rapidly After Infection with HIV - 1/05/05

Implications of the Increased Risk of Tuberculosis (TB) During the Course of HIV Infection - 1/05/05

Therapeutic Response of HIV-1 Subtype C in African Patients Coinfected with either Mycobacterium tuberculosis or Human Herpesvirus 8 - 1/03/05

The Extraordinary Hope of Antiretroviral Therapy in South Africa (Even for Patients with Tuberculosis or Kaposi Sarcoma!) - 1/03/05

The Effect of Clarithromycin, Fluconazole, and Rifabutin on Sulfamethoxazole Hydroxylamine Formation in HIV Patients (AACTG 283)  - 10/29/04

Two 8-month Regimens of Chemotherapy for Treatment of Tuberculosis Found Inferior to 6-month Standard Regimen  - 10/25/04

Adjunctive Dexamethasone Improves Survival in Tuberculous Meningitis  - 10/22/04

Outcome of HIV-Associated Tuberculosis in the HAART Era - 10/13/04

Does Tuberculosis Increase HIV Load? - 10/13/04

Combined TB/HIV Care Could Save 500,000 Lives in Africa Every Year, UN Says - 09/22/04

Paradoxical Reactions Are Common During Tuberculosis Treatment - 09/10/04

Safety and Effectiveness of Efavirenz with and without Rifampicin for the Treatment of Antiretroviral-naïve Patients Coinfected with Tuberculosis and HIV - 09/01/04

Use of Prednisolone in HIV-associated Tuberculous Pleurisy Is Not Recommended  - 08/16/04

Does Co-administration of Rifampicin and Fluconazole Negatively Impact the Clinical Status of Patients with AIDS and Cryptococcal Meningitis?  - 08/13/04

Paradoxical Reactions During Treatment of Tuberculosis in Patients with and without HIV Infection  - 08/06/04

Isoniazid Prophylaxis Has an Early and Significant Survival Benefit and Reduces TB in HIV Positive Children in Africa  - 07/21/04

Strategy for Successful Treatment of TB and HIV - 07/19/04

Incidence of Tuberculosis Pre and Post Introduction of ART in a Setting of High Tuberculosis-HIV Co-morbidity 7-12-04

Efavirenz 600 mg/day Versus 800 mg/day in HIV-infected Patients with Tuberculosis 7-12-04

Incidence of Tuberculosis Pre and Post Introduction of ART in a Setting of High Tuberculosis-HIV Co-morbidity  - 07/12/04

Lopinavir-Ritonavir Dose Adjustment and Therapeutic Drug Monitoring and Monitoring of Liver Function May Allow Concomitant Use of Rifampin in HIV Patients with Tuberculosis - 06/18/04

HIV Coinfection Does Not Alter Initial Clinical Presentation of Tuberculosis 03/03/04